Skip to main content
Premium Trial:

Request an Annual Quote

Omics Tools, MDx Stocks Rise with Biotech Surge in September

NEW YORK (GenomeWeb News) – Stocks for 'omics tools and molecular diagnostics firms climbed in September amid a general upswing for biotech stocks.

Among the 30 firms that comprise the GenomeWeb Daily News Index, only four saw a decline in their share price over the course of the month, and not a single stock was down in the double digits.

The highest percentage gainer for September was Rosetta Genomics, which was up around 34 percent. The firm's shares have been fairly volatile over the past few months and have traded as low as $3.88 on Aug. 17 and as high as $12.87 on July 3. Though it closed Friday at $7.19, the stock was down 10 percent in Monday afternoon trade at $6.50 after Rosetta reported a decline in first-half revenues.

Among the four firms to lose ground for the month Cepheid's shares fell furthest, down nearly 9 percent. Its month-to-month drop was due to an announcement late last week that the firm would miss revenue estimates for the third quarter due to interruption in supply of a part for its Xpert cartridges. Cepheid noted a day later at its analyst day that it plans to acquire a plastics firm that would make the molding for the cartridges.

In addition to Cepheid, Pacific Biosciences (-7 percent), Sequenom (-4 percent), and Vermillion (-2 percent) were the other decliners.

Overall, the GWDN Index was up nearly 4.4 percent, compared to the Nasdaq Biotech Index, which jumped 4.9 percent. The broader Nasdaq was up 1.6 percent and the Dow Jones Industrial Average climbed 2.6 percent.

During the month, four of the firms in in the GWDN Index paid out dividends — Agilent ($.10 on Sept. 28); Becton Dickinson ($.45 on Sept. 5); Danaher ($.025 on Sept. 26); and Thermo Fisher Scientific ($.13 on Sept. 13). Adjusting for those dividends, the Index was up slightly more than 4.4 percent.

0912Index.jpg

The Scan

Transcriptomic, Epigenetic Study Appears to Explain Anti-Viral Effects of TB Vaccine

Researchers report in Science Advances on an interferon signature and long-term shifts in monocyte cell DNA methylation in Bacille Calmette-Guérin-vaccinated infant samples.

DNA Storage Method Taps Into Gene Editing Technology

With a dual-plasmid system informed by gene editing, researchers re-wrote DNA sequences in E. coli to store Charles Dickens prose over hundreds of generations, as they recount in Science Advances.

Researchers Model Microbiome Dynamics in Effort to Understand Chronic Human Conditions

Investigators demonstrate in PLOS Computational Biology a computational method for following microbiome dynamics in the absence of longitudinally collected samples.

New Study Highlights Role of Genetics in ADHD

Researchers report in Nature Genetics on differences in genetic architecture between ADHD affecting children versus ADHD that persists into adulthood or is diagnosed in adults.